跳至主要内容
临床试验/NCT03701958
NCT03701958已完成不适用

Initial Case Series With Exalt Single-Use Duodenoscope

Boston Scientific Corporation12 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
12
主要终点
Successful ERCP procedure

研究概览

简要总结

To confirm procedural performance of the Exalt single-use duodenoscope in Endoscopic Retrograde Cholangio-Pancreatography (ERCP) procedures.

详细描述

This study is a prospective, multi-center case series of per standard of care ERCP procedures using a nonsignificant risk single-use duodenoscope. 35-70 cases will be included at up to 10 clinical sites. Patients who meet all eligibility criteria will be included and will have a clinically indicated ERCP procedure performed using the study device. Enrolled subjects will be followed for 7 days after their procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study.
  • Scheduled for a clinically indicated ERCP

排除标准

  • Altered pancreaticobiliary anatomy
  • Potentially vulnerable subjects, including, but not limited to pregnant women
  • Subjects for whom endoscopic techniques are contraindicated
  • Patients who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor
  • Investigator discretion

结局指标

主要结局

Successful ERCP procedure

时间窗: Procedure success is assessed at the end of the procedure (within 24 hours on study day 1).

The ability to complete the ERCP procedure for the intended indication(s); outcome reported as "success" or "failure". Examples include but are not limited to: biliary stent placement, pancreatic stent placement, sphincterotomy, and clearance of bile duct stones.

次要结局

  • Incidence of crossover from Exalt single-use duodenoscope to reusable duodenoscope(Incidence of crossover is monitored throughout the procedure (within 24 hours on study day 1).)
  • Endoscopist qualitative rating(Endoscopists will rate their experience with the Exalt single-use duodenoscope immediately following the completion of the study procedure (within 24 hours on study day 1).)
  • Evaluation of adverse events (SAEs) related to the device and/or the procedure(SAEs are assessed through 7 days after the procedure.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验